According to our (Global Info Research) latest study, the global Chinese Patent Drug Motherwort Granules market size was valued at US$ 119 million in 2025 and is forecast to a readjusted size of US$ 178 million by 2032 with a CAGR of 5.9% during review period.
Chinese Patent Drug Motherwort Granules are oral traditional Chinese patent medicines and simple preparations granule formed by water extraction, concentration, granulation, drying, and sub packaging with motherwort as the main flavor. It is usually managed according to OTC gynecology for regulating menstruation. Its main functions mainly focus on enriching blood, activating blood, regulating menstruation, and is used in scenarios such as blood deficiency, blood stagnation, and irregular menstruation. The upstream of the industrial chain includes the planting and harvesting of motherwort, processing of medicinal herbs, motherwort extract, sucrose/dextrin/sweeteners, packaging film, paper boxes, testing and GMP production equipment; The midstream includes traditional Chinese medicine extraction, concentration, granulation, drying, packaging, and quality testing; The downstream mainly includes pharmacies, hospital gynecology departments, primary healthcare institutions, e-commerce pharmacies, and cross-border traditional Chinese medicine retail.
Report Scope
This report is a detailed and comprehensive analysis for global Chinese Patent Drug Motherwort Granules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Chinese Patent Drug Motherwort Granules market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chinese Patent Drug Motherwort Granules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chinese Patent Drug Motherwort Granules market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Chinese Patent Drug Motherwort Granules market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Chinese Patent Drug Motherwort Granules
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Chinese Patent Drug Motherwort Granules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Beijing TRT Group, Hainan Huluwa Pharmaceutical Group, HAPHARM GROUP, Chengdu First Pharmaceutical, Beijing Great Wall Pharmaceutical Co., Ltd., Zhejiang Wecome Pharmaceutical, Yingke Biopharma, Jiangxi Pinxin Pharmaceutical, Shenyang Yongda Pharmaceutical, Dade Holdings Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Chinese Patent Drug Motherwort Granules market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market Segmentation
Market segment by Type
Large Sachet (15g)
Small Sachet (5g)
Combo Pack
Market segment by Sugar Content
Sugar-Containing
Sucrose-Free
Market segment by Application
Online Sales
Offline Sales
Major players covered
Beijing TRT Group
Hainan Huluwa Pharmaceutical Group
HAPHARM GROUP
Chengdu First Pharmaceutical
Beijing Great Wall Pharmaceutical Co., Ltd.
Zhejiang Wecome Pharmaceutical
Yingke Biopharma
Jiangxi Pinxin Pharmaceutical
Shenyang Yongda Pharmaceutical
Dade Holdings Group
Li Shizhen Pharmaceutical Group
Heilongjiang ZBD Pharmaceutical
Kangmei Baoning (Sichuan) Pharmaceutical
Anhui Huifeng Guoyao
Jiuhua Huayuan Pharmaceutical
Guangzhou Baiyunshan Pangao Shou Pharmaceutical
Anqing Huiyinbi Pharmaceutical
Shineway Pharmaceutical Group
Hengtuo Group Nanning Rensheng Pharmaceutical
Sichuan Deyuan Pharmaceutical Group
Shanghai Baolong Pharmaceutical
Herb Pharm
Gaia Herbs
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Chinese Patent Drug Motherwort Granules product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Chinese Patent Drug Motherwort Granules, with price, sales quantity, revenue, and global market share of Chinese Patent Drug Motherwort Granules from 2021 to 2026.
Chapter 3, the Chinese Patent Drug Motherwort Granules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chinese Patent Drug Motherwort Granules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Chinese Patent Drug Motherwort Granules market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Chinese Patent Drug Motherwort Granules.
Chapter 14 and 15, to describe Chinese Patent Drug Motherwort Granules sales channel, distributors, customers, research findings and conclusion.
Summary:
Get latest Market Research Reports on Chinese Patent Drug Motherwort Granules. Industry analysis & Market Report on Chinese Patent Drug Motherwort Granules is a syndicated market report, published as Global Chinese Patent Drug Motherwort Granules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Chinese Patent Drug Motherwort Granules market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.